Skip to content

A prospective validation study for the Obscure Gastrointestinal Bleeding Score to predict the usefulness of double-balloon endoscopy in patients with obscure gastrointestinal bleeding.

A prospective validation study for the Obscure Gastrointestinal Bleeding Score to predict the usefulness of double-balloon endoscopy in patients with obscure gastrointestinal bleeding. - A prospective validation study for the Obscure Gastrointestinal Bleeding Score to predict the usefulness of double-balloon endoscopy in patients with obscure gastrointestinal bleeding.

Status
Unknown
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000022995
Enrollment
120
Registered
2016-07-31
Start date
2016-07-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obscure gastrointestinal bleeding

Interventions

None listed

Sponsors

Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Full written informed consent is obtained from each patient. 2.Patients who are diagnosed as OGIB that is defined as overt bleeding or recurrent fecal occult bleeding with anemia of unknown origin at either conventional EGD or colonoscopy and who underwent capsule endoscopy.

Exclusion criteria

Exclusion criteria: 1.Patients who are pregnant. 2.Patients with severe general condition. 3.Patients who had already been enrolled in this study. 4.Patients judged as inappropriate candidates for the trial by the investigators

Design outcomes

Primary

MeasureTime frame
Sensitivity and specificity of OGIB score

Countries

Japan

Contacts

Public ContactMasanao Nakamura

Nagoya University Graduate School of Medicine Department of Gastroenterology and Hepatology

makamura@med.nagoya-u.ac.jp052-744-2180

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026